Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study

Author(s):
Iersel, L.B.J. van; Leede, E.M. de; Vahrmeijer, A.L.; Tijl, F.G.J.; Hartigh, J. den; Kuppen, P.J.K. (0000-0002-0294-3251); Hartgrink, H.H.; Gelderblom, H.; Nortier, J.W.R.; Tollenaar, R.A.E.M. (0000-0002-6831-6082); Velde, C.J.H. van de (0000-0003-0104-1800)
Published
2014
Publication type
Article / Letter to editor
Isolated hepatic perfusionLiver metastasesMelphalanOxaliplatinColorectal cancerUveal melanoma
Date issued
2014-11-30
Language
English
Is part of
EJSO - European Journal of Surgical Oncology (2014), Vol. 40, no. 11, p. 1557-1563
hdl
1887/108285
doi
10.1016/j.ejso.2014.06.010